Effectiveness of a Stigma Reduction Education Program on Stigma Score and Cervical Cancer Screening Uptake in Nepal

  • End date
    Mar 1, 2023
  • participants needed
  • sponsor
    Kathmandu University School of Medical Sciences
Updated on 4 October 2022
early diagnosis
cancer screening
cervical cancer screening
Accepts healthy volunteers


It is a cluster randomised control trial to assess the effectiveness of the stigma reduction education program cancer on cancer stigma score and cervical cancer screening uptake in Nepal


Despite the presence of ample evidence, that stigma is one of the major reasons for low screening coverage, Nepal does not have a single stigma reduction intervention targeted among women to increase cervical cancer screening coverage. Therefore, we aim to assess the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will conduct a two-arm open-label cluster-interventional study in Budanilkhantha Municipality. A computer-based program will randomly allocate the 12 wards of Budanilkhantha Municipality with an allocation ratio 1:1; 6 wards in intervention group and 6 wards in control group. We will conduct a "stigma reduction education program" in the intervention group. After that we will follow up the participants for2 months to see the effectiveness of a stigma reduction education program on stigma score and cervical cancer screening uptake in Nepal. We will analyze data using STATA 14. We will use independent tests to find the mean difference between cervical cancer screening uptake and cervical cancer stigma score. The difference in mean among the two groups will actually be the difference due to intervention given. Findings from this study will help managers and stakeholders to formulate and improve strategies on screening programs and develop programs to reduce stigma on cervical cancer among women in Nepal.

Condition Cervical Cancer, Stigma, Screening
Treatment "Stigma Reduction Education Program"
Clinical Study IdentifierNCT05489978
SponsorKathmandu University School of Medical Sciences
Last Modified on4 October 2022


Yes No Not Sure

Inclusion Criteria

Women aged 30-60 years (the age range recommended for VIA screening in Nepal
Married women
Residents of Budanilkantha Municipality

Exclusion Criteria

Women who have already undergone screening within 5 years
Women with hearing or mental disorders
Pregnant women
Less than 6 weeks postpartum
Mothers who had lived in the community for less than 6 months to perform seasonal work (e.g. in brick kilns) or visitors in the family
Women who are already diagnosed with cervical pre-cancer and cancer and have undergone hysterectomy
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note